Muscle Fatigue: How Your Muscles Respond to Brain Signals

Muscle cells contain mitochondria, the cellular powerhouses responsible for energy production. Sedentary muscle cells may contain around 100 mitochondria, while trained muscle cells can contain 2,000 to 5,000 mitochondria. This dramatic increase in mitochondrial density is a key adaptation to exercise training. Muscle tissue functions as a metabolic organ that can help reverse metabolic conditions. When muscle is built, new cells with insulin receptors are created, providing additional capacity for glucose uptake. The heart is the most mitochondria-rich muscle in the body, containing the highest density of energy-producing organelles because it must contract continuously and requires enormous energy production.

Exercise training induces fundamental changes at the cellular level. Hypertrophy involves existing muscle cells growing larger, while hyperplasia adds new muscle cells (about 5% contribution). Tendons strengthen through increased collagen fiber thickness and density. Myoglobin stores oxygen locally in muscle cells. Mitochondria increase in number and size, enhancing ATP production for energy. These adaptations collectively improve muscle function and exercise capacity.

To lower heart rate while maintaining cycling performance, cyclists must increase cardiac output by improving stroke volume through training adaptations including cardiac hypertrophy (thicker heart walls), increased arterial elasticity, enhanced muscle capillarization, and greater mitochondrial density. This is achieved through a balanced training approach: 80% steady-state endurance riding below the anaerobic threshold to build aerobic base and capillarization, combined with 20% high-intensity interval training to improve vascular elasticity and mitochondrial density. Beginners should focus exclusively on steady-state training for the first 3-4 months before introducing interval work.

Hypertrophy is the cellular phenomenon where muscle cells grow in size, and training for hypertrophy focuses on achieving this growth effect. Muscle hypertrophy can be divided into two main types: hypertrophy of contractile fibers (actin and myosin proteins forming sarcomeres) which increases muscle contraction force, and myopathic hypertrophy (growth of cytoplasm surrounding the fibers) which includes mitochondria and chemical reaction sites. During hypertrophy training, metabolic stress accumulates in muscle cells, creating an acidic environment that triggers cellular adaptation where the cell grows to increase its buffering capacity for acids. Different training goals target different muscle fiber types - strength training primarily targets fast-twitch fibers while endurance training targets slow-twitch fibers.

Cycling fitness improvement depends on two primary physiological adaptations: increased muscle capillarization (VEGF-mediated blood delivery for oxygen transport) and mitochondrial biogenesis (cellular powerhouses for fuel breakdown). Long slow endurance training promotes capillarization, while high-intensity efforts stimulate AMPK pathways for mitochondrial growth. Both are essential for aerobic performance. Junk miles aren't optimal, but motivational activities should be included. VO2 max efforts (4-5 min at 110-120% threshold) and sweet spot efforts (88-94%) provide complementary adaptations.

Lactate threshold training is one of the most important yet challenging sessions in a runner's weekly plan. The lactate threshold represents the highest sustainable pace an athlete can maintain for approximately one hour. For example, if a runner completes a 10K in 6 minutes/km, their lactate threshold pace is approximately 6 minutes/km. Most amateur athletes can sustain this threshold pace for 40-50 minutes, while elite athletes can maintain it closer to 60 minutes. This training can be done continuously (single effort) or fractionally (multiple blocks with short rests). Fractional training involves completing several blocks (e.g., four blocks of 10 minutes each) at threshold pace with brief recovery periods (about 1.5 minutes). Training at or slightly below lactate threshold improves the body's ability to clear lactate and delay fatigue, ultimately leading to faster race times when combined with other training modalities like VO2 max work, tempo runs, and long slow distance runs.

Lactate thresholds guide training intensity prescription. The minimum lactate test involves high-intensity exercise followed by ramp testing. The recovery lactate method measures lactate at 3, 8, and 12 minutes post-exhaustion, with the threshold determined from the recovery curve. Fixed lactate values (e.g., 4 mmol/L) are not individualized and may not represent true MLSS for each subject. Lactate thresholds correlate strongly with VO2max (maximum oxygen consumption). Endurance training should focus on intensities near lactate thresholds. Training closer to maximum oxygen consumption allows athletes to sustain higher workloads for longer periods. The goal is to maximize time spent in aerobic zones while developing capacity for higher intensities. Elite athletes can sustain significantly higher power outputs at their thresholds compared to amateurs.

To improve lactate threshold (the intensity at which lactate begins accumulating in blood), athletes must train above their current threshold. This creates the metabolic stress necessary for adaptation. Over time, the body adapts to handle higher lactate concentrations, effectively raising the threshold. This principle applies across all endurance sports—consistent training above threshold progressively shifts the lactate curve upward, allowing athletes to sustain higher intensities before fatigue onset.

For long-distance runners, the lactate threshold is more important than VO2 max in determining performance, because while VO2 max determines the body's capacity to deliver oxygen to working muscles, the lactate threshold determines the ability to sustain effort without accumulating lactic acid that causes muscle fatigue; beginners typically have their lactate threshold at 70-80% of their VO2 max, while elite marathonists can run at 91% of their VO2 max, meaning the lactate threshold progressively approaches the VO2 max with training and is the critical factor for endurance performance.

Lactate is a metabolic byproduct produced during anaerobic energy production, causing muscle burning and fatigue. The lactate threshold represents the intensity point where lactate accumulation begins. Two thresholds exist: aerobic threshold (gradual lactate rise, body still recycles lactate) and anaerobic threshold (abrupt lactate increase, body cannot recycle fast enough). The three-zone training model divides intensities: Zone 1 (below aerobic threshold) for recovery and long runs using fat oxidation; Zone 2 (between thresholds) for tempo runs with mixed metabolism; Zone 3 (above anaerobic threshold) for short, high-intensity efforts. Training zones can be calculated from VO2 max using percentages: aerobic threshold at 70-75% of VO2 max, anaerobic threshold at 88-92%. Daniels' method provides specific multipliers: aerobic threshold = VO2 max pace × 1.25, anaerobic threshold = VO2 max pace × 1.10.

Myasthenia gravis is an autoimmune disorder of the neuromuscular junction characterized by fluctuating muscle weakness that worsens in the afternoon, caused by antibodies against acetylcholine receptors (present in 85% of cases) or MuSK receptors (8% of cases), leading to reduced neurotransmitter binding and muscle fatigue; diagnosis involves clinical evaluation, ice pack test, edrophonium test, EMG showing decremental response, and serological testing, while treatment includes acetylcholinesterase inhibitors (pyridostigmine), immunosuppressive agents (steroids, cyclosporine, azathioprine), plasmapheresis, IV immunoglobulins, and thymectomy for patients with thymoma or positive AChR antibodies.

This section covers neuromuscular disorders. Guillain-Barré syndrome features ascending weakness with absent reflexes; investigation is nerve conduction study; CSF shows albuminocytological dissociation; antibodies against GM1/GD1a. Myasthenia gravis features ocular symptoms (ptosis, diplopia) and motor weakness without sensory symptoms; deep tendon reflexes are normal. Most specific test is acetylcholine receptor antibody; most sensitive is single-fiber EMG. CT thorax looks for thymoma. Myasthenic crisis is treated with plasma exchange or IVIG. Muscle disorders: Duchenne muscular dystrophy (proximal weakness, calf pseudohypertrophy); dermatomyositis (proximal weakness, cutaneous manifestations); hypothyroid myopathy (high CPK, high TSH); myotonic dystrophy (distal weakness, hatchet facies). Drug-induced myopathies include statins, fibrates, hydroxychloroquine, steroids.

Neuromuscular junction disorders include Lambert-Eaton myasthenic syndrome, botulism, and congenital myasthenia, but not tetanus. Myasthenia gravis is a postsynaptic disorder of the thymus gland, associated with HLA B8/DRW3 and other autoimmune disorders. Thymic hyperplasia is the most common thymic abnormality. Pathogenesis involves antibodies occupying NM receptors, reducing acetylcholine binding despite normal acetylcholine levels. Clinical features include spontaneous remission, proximal muscle involvement, and fatigability. The earliest affected muscle is levator palpebrae superioris. Single fiber electromyography has 99% sensitivity. Pyridostigmine is first-line treatment; prednisone for severe forms. Lambert-Eaton is presynaptic, associated with small cell carcinoma, and responds to 3,4-diaminopyridine. Brainstem stroke syndromes follow ipsilateral cranial nerve and contralateral corticospinal tract involvement. Midbrain syndromes include Weber's, Benedikt's, Claude's, Periaqueductal, and Nothnagel's. Pontine syndromes include Millard-Gubler, Foix, Raymond, and Locked-in syndrome. Medullary syndromes include lateral (Wallenberg) and medial (Dejerine) syndromes.

Myasthenia gravis is a chronic neuromuscular disorder where nerve signals fail to reach muscles properly, causing progressive muscle weakness and fatigue. The disease affects multiple body functions including facial expressions, walking, and respiratory muscles. Patients experience gradual deterioration over years, with periods of stability followed by rapid decline. The condition can lead to respiratory crises requiring hospitalization. Treatment options include plasmapheresis, which removes harmful antibodies from the blood to temporarily restore muscle function. The disease fundamentally changes how individuals experience their physical bodies and daily life.

Myasthenia gravis is an autoimmune disorder characterized by the formation of antibodies against acetylcholine receptors at the neuromuscular junction. These antibodies interfere with the normal function of acetylcholine receptors, reducing their ability to bind acetylcholine and open ion channels. As a result, the neuromuscular junction becomes less effective at transmitting signals from nerve to muscle, leading to muscle weakness and fatigue.